Suppr超能文献

短磷酸玻璃纤维增强聚乳酸(PLA)复合材料的细胞相容性和力学性能:偶联剂介导界面的影响

Cytocompatibility and Mechanical Properties of Short Phosphate Glass Fibre Reinforced Polylactic Acid (PLA) Composites: Effect of Coupling Agent Mediated Interface.

作者信息

Hasan Muhammad Sami, Ahmed Ifty, Parsons Andrew, Walker Gavin, Scotchford Colin

机构信息

Division of Materials, Mechanics and Structures, Faculty of Engineering, University of Nottingham, University Park, Nottingham NG7 2RD, UK.

出版信息

J Funct Biomater. 2012 Oct 16;3(4):706-25. doi: 10.3390/jfb3040706.

Abstract

In this study three chemical agents Amino-propyl-triethoxy-silane (APS), sorbitol ended PLA oligomer (SPLA) and Hexamethylene diisocyanate (HDI) were identified to be used as coupling agents to react with the phosphate glass fibre (PGF) reinforcement and the polylactic acid (PLA) polymer matrix of the composite. Composites were prepared with short chopped strand fibres (l = 20 mm, ϕ = 20 µm) in a random arrangement within PLA matrix. Improved, initial composite flexural strength (~20 MPa) was observed for APS treated fibres, which was suggested to be due to enhanced bonding between the fibres and polymer matrix. Both APS and HDI treated fibres were suggested to be covalently linked with the PLA matrix. The hydrophobicity induced by these coupling agents (HDI, APS) helped to resist hydrolysis of the interface and thus retained their mechanical properties for an extended period of time as compared to non-treated control. Approximately 70% of initial strength and 65% of initial modulus was retained by HDI treated fibre composites in contrast to the control, where only ~50% of strength and modulus was retained after 28 days of immersion in PBS at 37 °C. All coupling agent treated and control composites demonstrated good cytocompatibility which was comparable to the tissue culture polystyrene (TCP) control, supporting the use of these materials as coupling agent's within medical implant devices.

摘要

在本研究中,确定了三种化学试剂——氨丙基三乙氧基硅烷(APS)、山梨醇封端的聚乳酸低聚物(SPLA)和六亚甲基二异氰酸酯(HDI),用作偶联剂,使其与复合材料的磷酸玻璃纤维(PGF)增强材料和聚乳酸(PLA)聚合物基体发生反应。复合材料由短切纤维(长度l = 20 mm,直径ϕ = 20 µm)在PLA基体中随机排列制备而成。观察到经APS处理的纤维可提高复合材料的初始弯曲强度(约20 MPa),这被认为是由于纤维与聚合物基体之间的结合增强所致。研究表明,经APS和HDI处理的纤维均与PLA基体发生了共价连接。这些偶联剂(HDI、APS)诱导的疏水性有助于抵抗界面水解,因此与未处理的对照相比,它们的机械性能在更长时间内得以保持。与对照相比,经HDI处理的纤维复合材料在37℃下于PBS中浸泡28天后,仍保留了约70%的初始强度和65%的初始模量,而对照在浸泡后仅保留了约50%的强度和模量。所有经偶联剂处理的复合材料和对照复合材料均表现出良好的细胞相容性,与组织培养聚苯乙烯(TCP)对照相当,这支持了这些材料作为医疗植入装置中偶联剂的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e812/4030920/60862037b173/jfb-03-00706-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验